Keyphrases
Vascular Surgery
61%
Injection Drug Use
57%
Scotland
57%
Chronic Pulmonary Aspergillosis
46%
Antifungal Stewardship
46%
Fungal Diseases
46%
Collateral Consequences
46%
Hepatitis C Coinfection
46%
Ireland
46%
Groin Injecting
46%
Delphi Method
46%
Consensus Agreement
46%
Arterial Pseudoaneurysm
46%
Consensus Statement
46%
Health Impact
46%
Lung Infection
46%
Antifungal Therapy
46%
Severe Community-acquired Pneumonia
46%
Micro-elimination
46%
Front Door
46%
Intravenous Drug Use
46%
People Living with HIV (PLHIV)
46%
Retrospective Review
46%
Clarithromycin
46%
Outpatient Parenteral Antibiotic Therapy
46%
Moderate to Severe
46%
Tayside
46%
HIV Co-infection
46%
Ligation
38%
Triazole Drugs
30%
Length of Hospital Stay
30%
30-day Mortality
30%
Time to Clinical Stability
30%
CURB-65 Score
30%
HCV Treatment
28%
Intravenous Therapy
26%
Fungal Respiratory Infections
23%
Antifungal Agents
23%
Necrotizing Soft Tissue Infection
23%
Deep Vein Thrombosis
23%
Fungal Infection
23%
Amputation
23%
Pegylated Interferon
23%
SVR12
17%
Subacute Invasive Aspergillosis
15%
Voriconazole
15%
ICU Admission
15%
Computerized Tomography Angiography
15%
Substance Use Services
15%
Antibiotics
15%
Medicine and Dentistry
Drug Use
100%
Vascular Surgery
61%
Pseudoaneurysm
55%
Human Immunodeficiency Virus
46%
Mixed Infection
46%
Hepatitis C
46%
Outpatient
46%
Fungal Infection
46%
Antifungal Therapy
46%
Antimicrobial Therapy
46%
Clarithromycin
46%
Observational Study
46%
Community-Acquired Pneumonia
46%
Ligation
33%
Limb
27%
Infection
26%
Intravenous Drug Administration
26%
Surgery
24%
Mycosis
23%
Antifungal Agent
23%
Deep Vein Thrombosis
18%
Soft Tissue Infection
18%
Amputation
18%
Health Care Cost
18%
Abscess
18%
Peginterferon
15%
β-Lactam antibiotic
15%
Unit Surgery
15%
Antibiotics
15%
Artery Reconstruction
15%
Prevalence
15%
Illicit Drug
15%
Wound Management
15%
Likert Scale
15%
Angiography
15%
Computer Assisted Tomography
15%
Surgical Approach
15%
Holistic Care
15%
Surgeon
15%
Debridement
15%
Macrolide
15%
Intensive Care Unit
15%
Hazard Ratio
15%
Cryptococcal Meningitis
11%
Pneumocystis Jirovecii
11%
Candidemia
11%
Patient Selection
11%
Disease
11%
Allergic Bronchopulmonary Aspergillosis
11%
Diagnosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
46%
Clarithromycin
46%
Lung Aspergillosis
46%
Community Acquired Pneumonia
46%
HIV
46%
Mixed Infection
46%
Hepatitis C
46%
Lung Infection
46%
Antifungal Agent
46%
Triazole
38%
Aspergillus
23%
Voriconazole
15%
Beta Lactam Antibiotic
15%
Macrolide
15%
Intravenous Therapy
15%
Peginterferon
15%
Invasive Aspergillosis
15%
Therapeutic Drug Monitoring
15%
Infection
11%
Itraconazole
7%
Resistance to Antifungal Agent
7%
Lung Mycosis
7%
Reinfection
7%
Antivirus Agent
7%
Posaconazole
7%
Lung Disease
7%
Bacterial Infection
7%
Disease
7%
Drug Interaction
7%
Comorbidity
7%